Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3846699

COCCOCc1nc(-c2cnc3ccc(-c4c[nH]nc4-c4ccccc4F)cn23)no1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.37
LRRK2 Q5S007 1/20 0.37
TGFBR1 P36897 6/20 0.34
KIT P10721 3/20 0.34
PIK3CA P42336 3/20 0.33
PIK3CB P42338 1/20 0.33
MTOR P42345 1/20 0.33
CDK19 Q9BWU1 1/20 0.33
GABRA5 P31644 2/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
TP53 P04637 1/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
EIF2AK4 Q9P2K8 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5851891 0.94 TGFBR1 (0.36) LRRK2TGFBR1PIK3CAPIK3CBMTOR
Trifluoroacetic Acid SCHEMBL3857703 0.93 ABL1 (0.37) ABL1LRRK2TGFBR1KITPIK3CA
Trifluoroacetic Acid SCHEMBL3854224 0.87 TGFBR1 (0.36) TGFBR1PIK3CAPIK3CBMTORCDK19
Trifluoroacetic Acid SCHEMBL3856637 0.87 TGFBR1 (0.36) LRRK2TGFBR1KITPIK3CAPIK3CB
Trifluoroacetic Acid SCHEMBL3854281 0.82 MAPK1 (0.44) TGFBR1KITALDH1A1LMNA
Trifluoroacetic Acid SCHEMBL3850056 0.82 BDKRB1 (0.34) TGFBR1PIK3CAPIK3CBMTORCDK19
Trifluoroacetic Acid SCHEMBL3848210 0.80 TGFBR1 (0.35) TGFBR1PIK3CAPIK3CBMTORCDK19
Trifluoroacetic Acid SCHEMBL3851547 0.78 TGFBR1 (0.39) TGFBR1
Trifluoroacetic Acid SCHEMBL3849822 0.77 TGFBR1 (0.37) TGFBR1
SCHEMBL13874613 0.76 TGFBR1 (0.41) TGFBR1PIK3CAPIK3CBMTORCDK19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed